Mohsen Shafiepour

Mohsen Shafiepour


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2024 in Heliyon
Verified
Journal Article
Open access
ASAmin Sayyadi
Amin Sayyadi
FSFaranak Salajegheh
Faranak Salajegheh
BDBehnam Dalfardi
Behnam Dalfardi
MSMohsen Shafiepour
Mohsen Shafiepour
Mucormycosis can be lethal in people with immunocompromising conditions, especially Diabetes Mellitus. Correction of the underlying disorders, instant initiation of antifungal therapy, and surgical resection are the main components of treatment. Herin, we present the successful medical management of Mucormycosis in a patient with Diabetic Ketoacidosis and positive SARS-CoV-2 test who presented with a less seen condition: the simultaneity of mediastinal mass on one side and an endobronchial mass on the other. An 18-year-old male with a history of insulin-dependent DM from 4 years ago presented to our hospital with sudden onset dyspnea, chest pain, sore throat, hoarseness, cough, and sputum. Also, we detected unilateral swelling in the neck and multiple lymph nodes in the neck. Lung auscultation revealed bilateral generalized wheezing. Primary laboratory tests detected high blood sugar, metabolic acidosis, positive urine ketone, high ESR, positive CRP, and leukocytosis; his polymerase chain reaction (PCR) for SARS-CoV-2 was positive. Chest X-ray showed left upper lobe consolidation. Computed tomography scan (CT-scan) of the chest revealed a large collapse consolidation in the left lung, mild left side pleural effusion, mediastinal lymphadenopathy, and distention in the esophagus. With suspicion of malignancy, we performed flexible bronchoscopy and endobronchial Ultrasound (EBUS) which revealed a creamy tumoral lesion in the right main bronchus. The biopsy was consistent with Mucormycosis. We successfully treated Mucormycosis with Amphotericin-B liposomal. Mucormycosis can mimic the clinical characteristics of malignancy, and emphasize the importance of considering appropriate differential diagnoses because timely diagnosis and treatment is potentially life-saving in Mucormycosis.

1 August 2025 in Advanced Biomedical Research
Verified
Journal Article
Open access
NSNasrin Saberi Shahr-Babaki
Nasrin Saberi Shahr-Babaki
MFMitra Samareh Fekri
Mitra Samareh Fekri
MFMajid Fasihi-Harandi
Majid Fasihi-Harandi
BDBehnam Dalfardi
Behnam Dalfardi
MSMohsen Shafiepour
Mohsen Shafiepour
Background: Lophomonas blattarum is a protozoan, which is controversial regarding pathogenicity in the respiratory disease, and identification methods. This study investigated the presence of this protozoan in patients admitted to the intensive care unit (ICU) to assess these controversies. Materials and Methods: Samples of 83 patients hospitalized in the ICU ward of Afzalipoor, Shafa, and Shahid Bahonar hospitals (Kerman, Iran) were collected. The samples were examined using microscopy and real-time polymerase chain reaction (PCR) to check the presence of Lophomonas blattarum. Then, the efficiency of the method used was investigated using bioinformatics studies and the presence of Trichomonas tenax in the samples was investigated. Results: Of 83, 38 (46%) were female, 45 (54%) were male, and their age was 46.6 ± 14.45 years. Microscopic examination did not show any in the samples. The real-time PCR method showed 16 positive samples with primers that had been reported in other studies for Lophomonas blattarum. The bioinformatics study showed the method introduced in the other studies lacks the efficiency and specificity, and there is no information in the databases to design a molecular method based on the PCR for identification of Lophomonas blattarum. The results of examining the presence of Trichomonas tenax using the real-time PCR method showed that 16 samples with a positive result for Lofomonas blattarum contained Trichomonas tenax, which indicated that a misidentification had probably occurred. Conclusion: The current methods that are used to identify Lophomonas blattarum do not have the sensitivity and specificity required to identify this protozoan.

19 November 2022 in Shiraz E-Medical Journal
Verified
Journal Article
Open access
PDF file
RRRaziyeh Raz
Raziyeh Raz
BDBehnam Dalfardi
Behnam Dalfardi
SDShahriar Dabiri
Shahriar Dabiri
MZMohammad Javad Zahedi
Mohammad Javad Zahedi
HMHadi Mohagheghian
Hadi Mohagheghian
MSMohsen Shafiepour
Mohsen Shafiepour
Introduction: Sarcoidosis is a granulomatous inflammatory disorder characterized by the presence of non-caseating granulomas in affected tissues, such as lungs and lymph nodes. The precise etiology of sarcoidosis is not known yet. There are some reports on the association of sarcoidosis and other disorders that may similarly have an immunological basis, such as inflammatory bowel disease. In this study, we introduce a patient with ulcerative colitis (UC), whose disease was in remission for about 20 years, before presentation of her sarcoidosis. Case Presentation: A 48-year-old woman, a known case of UC for a period of 20 years, presented to the Adult Pulmonology Clinic with complaints of chronic non-productive cough, episodic night sweats, progressive dyspnea (initially on exertion, then at rest), fatigue, and significant weight loss. Her clinical manifestations began since about 1 year ago and aggravated over time. She was on regular follow-up by a gastroenterologist, and her UC was in remission. At the first visit, the patient’s physical examination showed stable hemodynamics, and normal breath sounds, and cardiac auscultation. Also, no significant finding was noted in her abdominal examination. Conclusions: Patients with UC who possess HLA-A*01 phenotype may possibly be more susceptible to developing sarcoidosis.

1 August 2023 in Current Respiratory Medicine Reviews
Verified
Journal Article
Closed access
PDF file
MSMohsen Shafiepour
Mohsen Shafiepour
BDBehnam Dalfardi
Behnam Dalfardi
SBSeyed Mehdi Hashemi Bajgani
Seyed Mehdi Hashemi Bajgani
MNMohammad Javad Najafzadeh
Mohammad Javad Najafzadeh
MSMohadeseh Shafiei
Mohadeseh Shafiei
Background: Acute respiratory distress syndrome (ARDS) following Covid-19 pneumonia is a common complication; using non-invasive ventilation (NIV) is one of the best options available. In the recent Covid-19 pandemic, we have seen a significant increase in barotrauma incidence following the use of NIV in patients with severe Covid-19 pneumonia. We aimed to identify the risk factors of barotrauma in patients with Covid-19 pneumonia under-going NIV. Methods: In this retrospective study, all adult patients with severe Covid-19 pneumonia who suffered from any form of barotrauma undergoing NIV from July to September 2021 in Afzalipour Hospital, Kerman, Iran were evaluated. Lab tests and NIV machine settings were collected from patients' files. A chi-square test and an independent t-test were used for analytical statistics. Results: Twenty patients with barotrauma secondary to severe Covid-19 pneumonia were enrolled. The most common manifestations of barotrauma were pneumomediastinum in 19 patients (95%). No significant relationship was seen between the occurrence of barotrauma and lab tests. The mean ± SD Inspiratory Positive Airway Pressure (IPAP) level in passed-away patients (17.8 ± 1.1) was significantly higher than in recovered patients (13.5 ± 0.5) (p = 0.04). Conclusion: According to the results of the study, using a low level of IPAP in the ventilator ma-chine settings of patients with barotrauma secondary to severe Covid-19 pneumonia will reduce the mortality rate, although its excessive reduction can cause pulmonary collapse and respiratory arrest as a result.

1 March 2021
Verified
Closed access
PDF file
HAHale Afshar
Hale Afshar
SBSina Bakhshaei
Sina Bakhshaei
MKMasoumeh Kahnooji
Masoumeh Kahnooji
MSMohsen Shafiepour
Mohsen Shafiepour
ALAhmad Alinaghi Langari
Ahmad Alinaghi Langari